| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 71 | 2024 | 4665 | 7.020 |
Why?
|
| Dendritic Cells, Follicular | 17 | 2019 | 53 | 5.810 |
Why?
|
| Receptors, Complement 3d | 34 | 2016 | 118 | 4.340 |
Why?
|
| Complement C4 | 52 | 2020 | 257 | 4.150 |
Why?
|
| Germinal Center | 20 | 2024 | 377 | 4.120 |
Why?
|
| Complement System Proteins | 36 | 2017 | 796 | 4.120 |
Why?
|
| Complement C3 | 56 | 2020 | 461 | 3.380 |
Why?
|
| Immunoglobulin M | 40 | 2017 | 1537 | 3.100 |
Why?
|
| Lupus Erythematosus, Systemic | 15 | 2024 | 2104 | 2.460 |
Why?
|
| Receptors, Complement 3b | 24 | 2013 | 145 | 2.450 |
Why?
|
| Antigens | 21 | 2024 | 1466 | 2.170 |
Why?
|
| Lymph Nodes | 22 | 2018 | 3476 | 1.950 |
Why?
|
| Reperfusion Injury | 22 | 2016 | 1027 | 1.860 |
Why?
|
| Autoimmunity | 15 | 2024 | 1349 | 1.850 |
Why?
|
| Antigen Presentation | 15 | 2023 | 1283 | 1.650 |
Why?
|
| Antibody Formation | 18 | 2014 | 1402 | 1.590 |
Why?
|
| Immunity, Innate | 25 | 2013 | 2961 | 1.530 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 2 | 2023 | 33 | 1.500 |
Why?
|
| Complement Activation | 25 | 2020 | 453 | 1.430 |
Why?
|
| Autoimmune Diseases | 9 | 2023 | 2134 | 1.390 |
Why?
|
| Antigen-Antibody Complex | 11 | 2020 | 517 | 1.360 |
Why?
|
| Autoantigens | 12 | 2020 | 892 | 1.330 |
Why?
|
| Immune Tolerance | 14 | 2022 | 2258 | 1.300 |
Why?
|
| Mice | 174 | 2024 | 81154 | 1.240 |
Why?
|
| Dendritic Cells | 18 | 2019 | 2720 | 1.220 |
Why?
|
| Receptors, IgG | 10 | 2019 | 581 | 1.210 |
Why?
|
| Receptors, Antigen, B-Cell | 11 | 2017 | 548 | 1.190 |
Why?
|
| Receptors, Complement | 13 | 2017 | 264 | 1.160 |
Why?
|
| Mice, Inbred C57BL | 87 | 2021 | 21824 | 1.150 |
Why?
|
| Complement C4a | 9 | 2020 | 19 | 1.110 |
Why?
|
| Animals | 210 | 2024 | 168660 | 1.090 |
Why?
|
| Synapses | 4 | 2020 | 1728 | 1.030 |
Why?
|
| Mice, Knockout | 73 | 2020 | 14563 | 1.000 |
Why?
|
| B-Lymphocyte Subsets | 8 | 2019 | 246 | 0.960 |
Why?
|
| Lymphocyte Activation | 20 | 2019 | 5524 | 0.930 |
Why?
|
| Antigens, CD19 | 6 | 2012 | 380 | 0.930 |
Why?
|
| T-Lymphocytes | 22 | 2024 | 10179 | 0.920 |
Why?
|
| Spleen | 21 | 2017 | 2359 | 0.870 |
Why?
|
| Immunoglobulin G | 31 | 2019 | 4561 | 0.760 |
Why?
|
| Complement Pathway, Classical | 15 | 2016 | 97 | 0.760 |
Why?
|
| Microglia | 7 | 2020 | 1267 | 0.730 |
Why?
|
| Mice, Transgenic | 31 | 2020 | 9731 | 0.730 |
Why?
|
| Neuroimmunomodulation | 1 | 2021 | 157 | 0.720 |
Why?
|
| Lectins, C-Type | 5 | 2019 | 589 | 0.710 |
Why?
|
| Peyer's Patches | 2 | 2019 | 121 | 0.700 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2022 | 985 | 0.690 |
Why?
|
| Immunity, Humoral | 5 | 2017 | 598 | 0.680 |
Why?
|
| Complement C4b | 11 | 2020 | 135 | 0.680 |
Why?
|
| Microscopy, Confocal | 9 | 2021 | 1962 | 0.680 |
Why?
|
| Influenza A virus | 4 | 2019 | 457 | 0.670 |
Why?
|
| Complement C3d | 4 | 2012 | 21 | 0.630 |
Why?
|
| Autoantibodies | 11 | 2023 | 2037 | 0.630 |
Why?
|
| Immunoglobulin Heavy Chains | 7 | 2019 | 659 | 0.630 |
Why?
|
| Antigen-Presenting Cells | 5 | 2016 | 972 | 0.620 |
Why?
|
| Self Tolerance | 4 | 2012 | 125 | 0.610 |
Why?
|
| Immunologic Memory | 9 | 2014 | 1347 | 0.610 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2017 | 87 | 0.590 |
Why?
|
| Cell Adhesion Molecules | 6 | 2019 | 1602 | 0.580 |
Why?
|
| Immunity, Mucosal | 1 | 2019 | 490 | 0.550 |
Why?
|
| Orthomyxoviridae Infections | 6 | 2019 | 247 | 0.550 |
Why?
|
| Influenza Vaccines | 5 | 2019 | 738 | 0.540 |
Why?
|
| Epitopes | 7 | 2024 | 2570 | 0.530 |
Why?
|
| Interferon Type I | 3 | 2019 | 541 | 0.520 |
Why?
|
| Cell Movement | 11 | 2019 | 5216 | 0.510 |
Why?
|
| Behavior, Animal | 2 | 2020 | 1880 | 0.510 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 3 | 2014 | 271 | 0.510 |
Why?
|
| Antibodies, Viral | 11 | 2019 | 3175 | 0.490 |
Why?
|
| Lymphocytes | 3 | 2019 | 2615 | 0.490 |
Why?
|
| Mannose-Binding Lectin | 5 | 2010 | 150 | 0.480 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2019 | 541 | 0.480 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2017 | 880 | 0.460 |
Why?
|
| Myocardial Reperfusion Injury | 4 | 2012 | 476 | 0.460 |
Why?
|
| Receptors, Cell Surface | 5 | 2019 | 2865 | 0.460 |
Why?
|
| Schizophrenic Psychology | 1 | 2020 | 1671 | 0.450 |
Why?
|
| Endosomes | 1 | 2015 | 518 | 0.440 |
Why?
|
| Immunity | 3 | 2014 | 1013 | 0.430 |
Why?
|
| Streptococcus pneumoniae | 3 | 2016 | 714 | 0.420 |
Why?
|
| Orthomyxoviridae | 3 | 2014 | 156 | 0.420 |
Why?
|
| Nonmuscle Myosin Type IIA | 2 | 2016 | 26 | 0.410 |
Why?
|
| Cytoprotection | 2 | 2012 | 209 | 0.410 |
Why?
|
| Myosin Heavy Chains | 3 | 2016 | 414 | 0.410 |
Why?
|
| Ribonucleoproteins | 2 | 2013 | 380 | 0.400 |
Why?
|
| Lymphoid Tissue | 3 | 2011 | 454 | 0.390 |
Why?
|
| Macrophages | 9 | 2017 | 5651 | 0.390 |
Why?
|
| Disease Models, Animal | 23 | 2023 | 18027 | 0.380 |
Why?
|
| Neurogenesis | 1 | 2017 | 838 | 0.380 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2013 | 1411 | 0.380 |
Why?
|
| Herpes Simplex | 3 | 2003 | 470 | 0.370 |
Why?
|
| Cells, Cultured | 18 | 2022 | 19232 | 0.360 |
Why?
|
| Antibodies, Antinuclear | 5 | 2007 | 326 | 0.360 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 2 | 2006 | 29 | 0.360 |
Why?
|
| Mice, Mutant Strains | 15 | 2008 | 1862 | 0.360 |
Why?
|
| Models, Immunological | 8 | 2010 | 527 | 0.360 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9440 | 0.360 |
Why?
|
| Major Histocompatibility Complex | 12 | 2023 | 936 | 0.350 |
Why?
|
| Stromal Cells | 5 | 2018 | 1356 | 0.350 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 1420 | 0.350 |
Why?
|
| Antibody Affinity | 5 | 2020 | 254 | 0.350 |
Why?
|
| Endocytosis | 2 | 2013 | 985 | 0.340 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2024 | 2540 | 0.340 |
Why?
|
| Mast Cells | 8 | 2005 | 1544 | 0.340 |
Why?
|
| Nerve Net | 2 | 2020 | 2173 | 0.340 |
Why?
|
| Jejunum | 2 | 2008 | 480 | 0.330 |
Why?
|
| Schizophrenia | 4 | 2020 | 6865 | 0.330 |
Why?
|
| Intestinal Mucosa | 2 | 2019 | 3038 | 0.330 |
Why?
|
| Peripheral Nervous System | 1 | 2009 | 150 | 0.320 |
Why?
|
| Flow Cytometry | 14 | 2017 | 5973 | 0.320 |
Why?
|
| Antibodies | 5 | 2019 | 2459 | 0.320 |
Why?
|
| Glomerulonephritis | 6 | 2001 | 372 | 0.310 |
Why?
|
| Herpesvirus 1, Human | 3 | 2003 | 743 | 0.310 |
Why?
|
| Myeloid Cells | 3 | 2013 | 808 | 0.310 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2021 | 4386 | 0.300 |
Why?
|
| NFATC Transcription Factors | 2 | 2006 | 381 | 0.300 |
Why?
|
| RNA | 1 | 2017 | 2748 | 0.300 |
Why?
|
| Homeodomain Proteins | 10 | 2010 | 2419 | 0.300 |
Why?
|
| Peritonitis | 5 | 2002 | 365 | 0.290 |
Why?
|
| Signal Transduction | 19 | 2019 | 23398 | 0.290 |
Why?
|
| Inflammation | 14 | 2017 | 10629 | 0.290 |
Why?
|
| Immune Complex Diseases | 4 | 2001 | 54 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 12 | 2017 | 9272 | 0.290 |
Why?
|
| Clonal Deletion | 3 | 2004 | 79 | 0.290 |
Why?
|
| Immunoglobulin Isotypes | 4 | 2016 | 158 | 0.280 |
Why?
|
| Blood-Borne Pathogens | 1 | 2006 | 52 | 0.280 |
Why?
|
| Interferon-alpha | 2 | 2023 | 895 | 0.270 |
Why?
|
| Haptens | 6 | 2012 | 166 | 0.270 |
Why?
|
| Chimera | 5 | 2017 | 484 | 0.270 |
Why?
|
| Bone Marrow Cells | 6 | 2013 | 2509 | 0.270 |
Why?
|
| Shock, Septic | 5 | 2004 | 775 | 0.270 |
Why?
|
| Amino Acid Sequence | 24 | 2020 | 13809 | 0.260 |
Why?
|
| Complement Pathway, Alternative | 5 | 2006 | 126 | 0.260 |
Why?
|
| Time-Lapse Imaging | 2 | 2018 | 195 | 0.260 |
Why?
|
| Milk Proteins | 3 | 2001 | 167 | 0.260 |
Why?
|
| Lymph | 2 | 2015 | 80 | 0.260 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2007 | 160 | 0.250 |
Why?
|
| DNA-Binding Proteins | 13 | 2009 | 9648 | 0.250 |
Why?
|
| Humans | 108 | 2023 | 743811 | 0.240 |
Why?
|
| Ankle | 1 | 2007 | 327 | 0.240 |
Why?
|
| Immunoglobulins | 3 | 2002 | 881 | 0.230 |
Why?
|
| Steroid 21-Hydroxylase | 6 | 1994 | 34 | 0.230 |
Why?
|
| Steroid Hydroxylases | 5 | 1986 | 96 | 0.230 |
Why?
|
| Neurons | 5 | 2021 | 9336 | 0.230 |
Why?
|
| Foot | 1 | 2007 | 527 | 0.230 |
Why?
|
| Membrane Glycoproteins | 9 | 2018 | 3769 | 0.220 |
Why?
|
| Base Sequence | 21 | 2020 | 12798 | 0.220 |
Why?
|
| Antigens, CD | 8 | 2012 | 4026 | 0.220 |
Why?
|
| Lectins | 3 | 2006 | 513 | 0.220 |
Why?
|
| Fetal Death | 1 | 2005 | 448 | 0.220 |
Why?
|
| Myocardium | 3 | 2016 | 4775 | 0.220 |
Why?
|
| Streptococcus agalactiae | 3 | 2003 | 375 | 0.220 |
Why?
|
| Green Fluorescent Proteins | 4 | 2013 | 2086 | 0.210 |
Why?
|
| Peptides | 7 | 2014 | 4406 | 0.210 |
Why?
|
| Lipopolysaccharides | 6 | 2007 | 2217 | 0.210 |
Why?
|
| Bone Marrow Transplantation | 8 | 2009 | 2764 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 17 | 2018 | 6380 | 0.200 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2000 | 188 | 0.200 |
Why?
|
| Phagocytosis | 5 | 2016 | 1539 | 0.200 |
Why?
|
| Intestine, Small | 2 | 2019 | 1240 | 0.200 |
Why?
|
| Radiation Chimera | 4 | 2006 | 223 | 0.200 |
Why?
|
| Macrophage-1 Antigen | 5 | 2012 | 290 | 0.200 |
Why?
|
| Serum Amyloid P-Component | 2 | 2011 | 47 | 0.190 |
Why?
|
| Complement C3-C5 Convertases, Classical Pathway | 1 | 2020 | 3 | 0.190 |
Why?
|
| Blood Vessels | 2 | 2018 | 1124 | 0.190 |
Why?
|
| Drosophila Proteins | 2 | 2001 | 1709 | 0.190 |
Why?
|
| Synaptosomes | 1 | 2020 | 115 | 0.190 |
Why?
|
| Muramidase | 4 | 2005 | 174 | 0.190 |
Why?
|
| Adoptive Transfer | 8 | 2009 | 844 | 0.190 |
Why?
|
| Repressor Proteins | 4 | 2000 | 3024 | 0.180 |
Why?
|
| Gout | 1 | 2007 | 571 | 0.180 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2000 | 180 | 0.180 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 2 | 2001 | 97 | 0.180 |
Why?
|
| Chemokine CCL19 | 1 | 2019 | 35 | 0.180 |
Why?
|
| Antibody Specificity | 4 | 2010 | 1095 | 0.180 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4033 | 0.180 |
Why?
|
| Immunohistochemistry | 9 | 2017 | 11360 | 0.180 |
Why?
|
| Microscopy, Electron | 5 | 2009 | 2646 | 0.180 |
Why?
|
| Interleukin-3 | 2 | 2000 | 444 | 0.180 |
Why?
|
| Antigens, Viral | 6 | 2014 | 1035 | 0.180 |
Why?
|
| Muscle, Skeletal | 7 | 2009 | 4925 | 0.170 |
Why?
|
| Intestines | 3 | 2004 | 1923 | 0.170 |
Why?
|
| Serine Endopeptidases | 3 | 2018 | 1073 | 0.170 |
Why?
|
| Cell Differentiation | 10 | 2020 | 11478 | 0.170 |
Why?
|
| Dendritic Spines | 1 | 2020 | 233 | 0.170 |
Why?
|
| Apoptosis | 8 | 2020 | 9718 | 0.170 |
Why?
|
| Hindlimb | 4 | 2009 | 503 | 0.170 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2017 | 171 | 0.170 |
Why?
|
| Clone Cells | 2 | 2021 | 1692 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2017 | 3874 | 0.170 |
Why?
|
| Gelatinases | 1 | 2018 | 94 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 5 | 2017 | 6170 | 0.160 |
Why?
|
| Gene Dosage | 2 | 2020 | 1252 | 0.160 |
Why?
|
| Models, Animal | 3 | 2019 | 2172 | 0.160 |
Why?
|
| Kidney Glomerulus | 6 | 2002 | 697 | 0.160 |
Why?
|
| Trans-Activators | 4 | 2001 | 2927 | 0.160 |
Why?
|
| Monocytes | 6 | 2017 | 2593 | 0.160 |
Why?
|
| Collagen | 3 | 2014 | 2681 | 0.160 |
Why?
|
| Adjuvants, Immunologic | 3 | 2017 | 999 | 0.160 |
Why?
|
| Squalene | 1 | 2017 | 32 | 0.160 |
Why?
|
| Molecular Sequence Data | 16 | 2006 | 18107 | 0.160 |
Why?
|
| Polysorbates | 1 | 2017 | 41 | 0.150 |
Why?
|
| Neoplasm Seeding | 1 | 2018 | 87 | 0.150 |
Why?
|
| Immunophenotyping | 2 | 2017 | 1880 | 0.150 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 157 | 0.150 |
Why?
|
| DNA | 15 | 2014 | 7295 | 0.150 |
Why?
|
| Complement C1 Inactivator Proteins | 1 | 1997 | 93 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2017 | 2503 | 0.150 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2017 | 291 | 0.140 |
Why?
|
| Immunization | 4 | 2014 | 1255 | 0.140 |
Why?
|
| Injections, Intravenous | 3 | 2003 | 1422 | 0.140 |
Why?
|
| Superoxide Dismutase | 2 | 2009 | 595 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 4749 | 0.140 |
Why?
|
| Diagnostic Equipment | 1 | 2015 | 10 | 0.140 |
Why?
|
| Skin Temperature | 1 | 2015 | 93 | 0.130 |
Why?
|
| Ischemia | 3 | 2006 | 1907 | 0.130 |
Why?
|
| Genes | 8 | 1988 | 1893 | 0.130 |
Why?
|
| Immunoglobulin lambda-Chains | 2 | 2007 | 87 | 0.130 |
Why?
|
| Immune Evasion | 1 | 2019 | 360 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2012 | 524 | 0.130 |
Why?
|
| Fibroblasts | 3 | 2014 | 4162 | 0.130 |
Why?
|
| Complement Factor B | 6 | 2008 | 72 | 0.130 |
Why?
|
| Receptors, Immunologic | 2 | 2016 | 1423 | 0.130 |
Why?
|
| Chromosome Mapping | 10 | 1988 | 4737 | 0.130 |
Why?
|
| Rhamnose | 1 | 2014 | 18 | 0.130 |
Why?
|
| Phenotype | 8 | 2017 | 16361 | 0.130 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 1453 | 0.130 |
Why?
|
| Female | 46 | 2020 | 380020 | 0.130 |
Why?
|
| Membrane Proteins | 4 | 2018 | 7880 | 0.130 |
Why?
|
| Neutrophils | 12 | 2013 | 3718 | 0.120 |
Why?
|
| Ion Channels | 1 | 2019 | 1056 | 0.120 |
Why?
|
| Epidermis | 1 | 2017 | 529 | 0.120 |
Why?
|
| Vital Signs | 1 | 2015 | 142 | 0.120 |
Why?
|
| Papain | 1 | 2014 | 64 | 0.120 |
Why?
|
| Clonal Anergy | 3 | 2006 | 169 | 0.120 |
Why?
|
| HLA Antigens | 4 | 1994 | 1382 | 0.120 |
Why?
|
| Genetic Linkage | 8 | 2004 | 2419 | 0.120 |
Why?
|
| Male | 44 | 2020 | 349776 | 0.120 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2016 | 349 | 0.120 |
Why?
|
| Nerve Degeneration | 2 | 2009 | 748 | 0.120 |
Why?
|
| Biological Transport | 2 | 2009 | 2119 | 0.120 |
Why?
|
| Antibody-Producing Cells | 3 | 2003 | 143 | 0.120 |
Why?
|
| Chemokines | 2 | 2019 | 968 | 0.120 |
Why?
|
| Complement C5a | 3 | 2005 | 107 | 0.120 |
Why?
|
| Antibodies, Bacterial | 4 | 2003 | 1470 | 0.120 |
Why?
|
| Nucleolus Organizer Region | 1 | 2013 | 26 | 0.120 |
Why?
|
| Kidney | 4 | 2017 | 7185 | 0.120 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 1895 | 0.120 |
Why?
|
| Carrier Proteins | 5 | 2015 | 5021 | 0.110 |
Why?
|
| Complement C5 | 4 | 2007 | 112 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2004 | 4422 | 0.110 |
Why?
|
| Immunization, Passive | 3 | 2006 | 623 | 0.110 |
Why?
|
| Vaccination | 2 | 2017 | 3275 | 0.110 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 11708 | 0.110 |
Why?
|
| Receptors, CXCR3 | 1 | 2014 | 237 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 2914 | 0.110 |
Why?
|
| Water | 1 | 2019 | 1394 | 0.110 |
Why?
|
| Cytokines | 7 | 2021 | 7324 | 0.110 |
Why?
|
| Complement C3c | 1 | 2012 | 7 | 0.110 |
Why?
|
| Cell Communication | 2 | 2017 | 1621 | 0.110 |
Why?
|
| Complement C1q | 4 | 2006 | 93 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2022 | 2575 | 0.110 |
Why?
|
| Th2 Cells | 3 | 2014 | 1061 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2001 | 2453 | 0.110 |
Why?
|
| Killer Cells, Natural | 3 | 2019 | 2131 | 0.110 |
Why?
|
| Guinea Pigs | 3 | 2001 | 1386 | 0.100 |
Why?
|
| Complement C2 | 3 | 1997 | 72 | 0.100 |
Why?
|
| Ligands | 2 | 2017 | 3281 | 0.100 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 2011 | 62 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2007 | 4437 | 0.100 |
Why?
|
| Cell Survival | 5 | 2014 | 5881 | 0.100 |
Why?
|
| Neoplasms | 2 | 2019 | 21675 | 0.100 |
Why?
|
| Transcription Factors | 4 | 2000 | 12209 | 0.100 |
Why?
|
| Complement C3b | 5 | 2000 | 106 | 0.100 |
Why?
|
| Macrophage Activation | 2 | 2017 | 559 | 0.100 |
Why?
|
| Complement Inactivator Proteins | 5 | 2006 | 79 | 0.100 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2002 | 547 | 0.100 |
Why?
|
| Immunoglobulin E | 1 | 2017 | 1463 | 0.100 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 2 | 2019 | 97 | 0.100 |
Why?
|
| Streptococcal Infections | 1 | 1995 | 636 | 0.100 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2015 | 671 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2177 | 0.100 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 1176 | 0.100 |
Why?
|
| Receptors, Chemokine | 1 | 2014 | 670 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2012 | 243 | 0.100 |
Why?
|
| Lymphocyte Count | 4 | 2002 | 793 | 0.090 |
Why?
|
| Species Specificity | 2 | 2014 | 2480 | 0.090 |
Why?
|
| Spinal Cord | 2 | 2009 | 1809 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-ets | 4 | 2000 | 318 | 0.090 |
Why?
|
| Molecular Weight | 3 | 2009 | 2253 | 0.090 |
Why?
|
| Clodronic Acid | 1 | 2010 | 58 | 0.090 |
Why?
|
| Immunotherapy, Active | 1 | 2010 | 60 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 2924 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2014 | 712 | 0.090 |
Why?
|
| Brain | 5 | 2023 | 26345 | 0.090 |
Why?
|
| Dendrimers | 1 | 2010 | 68 | 0.090 |
Why?
|
| Nociceptors | 1 | 2013 | 432 | 0.090 |
Why?
|
| Histidine | 1 | 1990 | 312 | 0.090 |
Why?
|
| Cell Compartmentation | 1 | 2010 | 402 | 0.090 |
Why?
|
| Cerebellar Neoplasms | 1 | 2015 | 587 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1157 | 0.090 |
Why?
|
| Polymorphism, Genetic | 10 | 1987 | 4326 | 0.090 |
Why?
|
| Actins | 3 | 2013 | 2121 | 0.090 |
Why?
|
| Interleukin-4 | 2 | 2014 | 1147 | 0.090 |
Why?
|
| Peritoneum | 2 | 2002 | 227 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2019 | 10477 | 0.090 |
Why?
|
| Structure-Activity Relationship | 4 | 2006 | 3128 | 0.090 |
Why?
|
| Medulloblastoma | 1 | 2015 | 683 | 0.090 |
Why?
|
| Molecular Mimicry | 1 | 2010 | 201 | 0.090 |
Why?
|
| HIV Infections | 1 | 2015 | 16715 | 0.090 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 535 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 988 | 0.080 |
Why?
|
| Alleles | 13 | 2016 | 6934 | 0.080 |
Why?
|
| Chemokine CXCL13 | 1 | 2009 | 54 | 0.080 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2014 | 226 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1733 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 850 | 0.080 |
Why?
|
| Arteries | 1 | 2014 | 1119 | 0.080 |
Why?
|
| Cecum | 2 | 2000 | 237 | 0.080 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 608 | 0.080 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 2 | 2008 | 142 | 0.080 |
Why?
|
| Lymphocyte Transfusion | 1 | 2009 | 236 | 0.080 |
Why?
|
| Polysaccharides, Bacterial | 2 | 2003 | 578 | 0.080 |
Why?
|
| Endopeptidases | 3 | 2018 | 772 | 0.080 |
Why?
|
| Integrin alphaXbeta2 | 3 | 2003 | 29 | 0.080 |
Why?
|
| Aspartic Acid | 1 | 1990 | 576 | 0.080 |
Why?
|
| Chromosomes, Human, 6-12 and X | 2 | 1986 | 80 | 0.080 |
Why?
|
| Antigens, Differentiation | 2 | 2007 | 927 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2017 | 1162 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2015 | 1546 | 0.080 |
Why?
|
| HLA-D Antigens | 1 | 1987 | 134 | 0.080 |
Why?
|
| DNA Restriction Enzymes | 6 | 1987 | 570 | 0.080 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 390 | 0.080 |
Why?
|
| Sepsis | 2 | 2000 | 2593 | 0.070 |
Why?
|
| Chromatin | 1 | 1999 | 2931 | 0.070 |
Why?
|
| Immunoglobulin D | 1 | 2007 | 56 | 0.070 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 1400 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2712 | 0.070 |
Why?
|
| Immunity, Active | 2 | 1998 | 60 | 0.070 |
Why?
|
| Capillary Permeability | 3 | 2006 | 798 | 0.070 |
Why?
|
| Amyloid | 1 | 2012 | 795 | 0.070 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2007 | 69 | 0.070 |
Why?
|
| Proteinuria | 3 | 1999 | 658 | 0.070 |
Why?
|
| Gene Expression | 4 | 2012 | 7793 | 0.070 |
Why?
|
| Trisaccharides | 1 | 2006 | 50 | 0.070 |
Why?
|
| Complement C3a | 2 | 2005 | 69 | 0.070 |
Why?
|
| Toll-Like Receptors | 2 | 2001 | 593 | 0.070 |
Why?
|
| Bacteriophage phi X 174 | 2 | 1996 | 20 | 0.070 |
Why?
|
| HIV | 1 | 2014 | 1604 | 0.070 |
Why?
|
| Myosin Type II | 1 | 2006 | 68 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 500 | 0.070 |
Why?
|
| Liver Regeneration | 1 | 2008 | 211 | 0.070 |
Why?
|
| Herpes Simplex Virus Vaccines | 1 | 2006 | 18 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1987 | 380 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2013 | 721 | 0.070 |
Why?
|
| Graft vs Host Disease | 1 | 2019 | 2958 | 0.070 |
Why?
|
| Mutation | 9 | 2009 | 29777 | 0.070 |
Why?
|
| L-Selectin | 2 | 2016 | 214 | 0.070 |
Why?
|
| Syndecan-1 | 1 | 2007 | 165 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 3583 | 0.070 |
Why?
|
| Mannose-Binding Lectins | 1 | 2006 | 100 | 0.070 |
Why?
|
| gamma-Globulins | 2 | 2003 | 124 | 0.070 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 607 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2010 | 3749 | 0.070 |
Why?
|
| Homeostasis | 2 | 2014 | 3337 | 0.070 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 834 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3622 | 0.070 |
Why?
|
| Mesentery | 1 | 2006 | 205 | 0.070 |
Why?
|
| Chromosome Deletion | 7 | 1987 | 1396 | 0.070 |
Why?
|
| RNA Interference | 1 | 2015 | 2890 | 0.070 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2005 | 49 | 0.070 |
Why?
|
| Troponin I | 1 | 2010 | 619 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 2692 | 0.070 |
Why?
|
| Phenylacetates | 2 | 2002 | 114 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1988 | 657 | 0.070 |
Why?
|
| Parathyroid Neoplasms | 1 | 2007 | 245 | 0.070 |
Why?
|
| Dysgammaglobulinemia | 1 | 2005 | 21 | 0.070 |
Why?
|
| Brain Injuries | 2 | 2008 | 2029 | 0.070 |
Why?
|
| Receptors, Fc | 2 | 2015 | 541 | 0.070 |
Why?
|
| Leukocyte Count | 2 | 2000 | 1588 | 0.060 |
Why?
|
| Time Factors | 7 | 2012 | 40038 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2009 | 1098 | 0.060 |
Why?
|
| Antigens, Surface | 1 | 2010 | 1663 | 0.060 |
Why?
|
| Th17 Cells | 1 | 2011 | 766 | 0.060 |
Why?
|
| Leukocytes | 4 | 2003 | 2044 | 0.060 |
Why?
|
| Dogs | 2 | 2019 | 3911 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 3 | 2001 | 259 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2012 | 897 | 0.060 |
Why?
|
| Receptors, IgE | 1 | 2007 | 389 | 0.060 |
Why?
|
| Primary Myelofibrosis | 1 | 2007 | 215 | 0.060 |
Why?
|
| Nitrophenols | 2 | 2002 | 172 | 0.060 |
Why?
|
| Complement C3-C5 Convertases | 3 | 1997 | 37 | 0.060 |
Why?
|
| Gene Targeting | 4 | 2004 | 879 | 0.060 |
Why?
|
| Herpesvirus 2, Human | 1 | 2006 | 189 | 0.060 |
Why?
|
| Cloning, Molecular | 9 | 1996 | 4320 | 0.060 |
Why?
|
| Phthalazines | 1 | 2007 | 359 | 0.060 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2019 | 421 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 2074 | 0.060 |
Why?
|
| Transfection | 5 | 2012 | 5892 | 0.060 |
Why?
|
| Virion | 1 | 2007 | 433 | 0.060 |
Why?
|
| Hippocampus | 1 | 2017 | 3672 | 0.060 |
Why?
|
| Muscles | 1 | 2009 | 1613 | 0.060 |
Why?
|
| Cell Line | 9 | 2019 | 15993 | 0.060 |
Why?
|
| Protein Transport | 1 | 2010 | 1988 | 0.060 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 2004 | 18 | 0.060 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2006 | 273 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4463 | 0.060 |
Why?
|
| Protein Binding | 2 | 2014 | 9377 | 0.060 |
Why?
|
| Ovalbumin | 1 | 2006 | 719 | 0.060 |
Why?
|
| Mice, Inbred Strains | 3 | 2005 | 1826 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 1996 | 3706 | 0.060 |
Why?
|
| Plaque, Amyloid | 1 | 2008 | 729 | 0.060 |
Why?
|
| Rheumatoid Factor | 1 | 2004 | 188 | 0.060 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 291 | 0.060 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2004 | 92 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 906 | 0.060 |
Why?
|
| Genetic Variation | 4 | 2016 | 6535 | 0.060 |
Why?
|
| Enzyme Precursors | 1 | 1984 | 176 | 0.060 |
Why?
|
| Isoantibodies | 3 | 2003 | 679 | 0.060 |
Why?
|
| Mice, 129 Strain | 2 | 2014 | 386 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3677 | 0.060 |
Why?
|
| Th1 Cells | 2 | 2006 | 1057 | 0.060 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 2004 | 318 | 0.060 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2004 | 173 | 0.060 |
Why?
|
| Luminescent Proteins | 2 | 2018 | 853 | 0.060 |
Why?
|
| Opsonin Proteins | 3 | 2001 | 150 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 3660 | 0.060 |
Why?
|
| DNA Primers | 6 | 2011 | 2891 | 0.060 |
Why?
|
| Recombinant Proteins | 5 | 2012 | 6620 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2014 | 1898 | 0.050 |
Why?
|
| Pericytes | 2 | 2018 | 293 | 0.050 |
Why?
|
| Hybridomas | 1 | 2004 | 452 | 0.050 |
Why?
|
| Phosphotyrosine | 2 | 2001 | 457 | 0.050 |
Why?
|
| Neprilysin | 2 | 1996 | 439 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2001 | 1581 | 0.050 |
Why?
|
| Cell Separation | 1 | 2008 | 1750 | 0.050 |
Why?
|
| Anthelmintics | 1 | 2003 | 62 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1789 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2008 | 1121 | 0.050 |
Why?
|
| Antibodies, Fungal | 1 | 2002 | 32 | 0.050 |
Why?
|
| Histocompatibility Antigens | 1 | 2023 | 471 | 0.050 |
Why?
|
| Schistosomiasis mansoni | 1 | 2003 | 85 | 0.050 |
Why?
|
| Complement Factor D | 1 | 2001 | 68 | 0.050 |
Why?
|
| Arthritis | 1 | 2007 | 661 | 0.050 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2002 | 158 | 0.050 |
Why?
|
| Cell Degranulation | 2 | 2005 | 287 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 17439 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 2011 | 0.050 |
Why?
|
| Epilepsy | 1 | 2017 | 3284 | 0.050 |
Why?
|
| Cryptococcus neoformans | 1 | 2002 | 119 | 0.050 |
Why?
|
| Vitiligo | 1 | 2002 | 89 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4152 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2006 | 612 | 0.050 |
Why?
|
| Bacterial Infections | 2 | 2001 | 1400 | 0.050 |
Why?
|
| Lymphopenia | 1 | 2003 | 285 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2023 | 1475 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 791 | 0.050 |
Why?
|
| Depression | 1 | 2020 | 7760 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2017 | 571 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 959 | 0.050 |
Why?
|
| Peritoneal Lavage | 1 | 2000 | 35 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2002 | 410 | 0.050 |
Why?
|
| Metalloendopeptidases | 2 | 2012 | 396 | 0.050 |
Why?
|
| Chickens | 2 | 2000 | 864 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 1984 | 914 | 0.050 |
Why?
|
| Rabbits | 7 | 2001 | 4894 | 0.050 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 2000 | 8 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 2017 | 0.050 |
Why?
|
| Ascitic Fluid | 1 | 2000 | 192 | 0.050 |
Why?
|
| Pyridines | 2 | 2014 | 2827 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2006 | 1800 | 0.050 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2000 | 39 | 0.050 |
Why?
|
| Lung | 5 | 2018 | 9858 | 0.040 |
Why?
|
| Prion Diseases | 1 | 2001 | 88 | 0.040 |
Why?
|
| Mice, Inbred DBA | 2 | 1981 | 642 | 0.040 |
Why?
|
| Movement | 1 | 2007 | 1471 | 0.040 |
Why?
|
| Binding Sites, Antibody | 1 | 2000 | 349 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2002 | 424 | 0.040 |
Why?
|
| Ligation | 1 | 2000 | 452 | 0.040 |
Why?
|
| Haplotypes | 3 | 2016 | 2779 | 0.040 |
Why?
|
| RNA, Messenger | 8 | 2016 | 13028 | 0.040 |
Why?
|
| Glucans | 1 | 1999 | 71 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 1997 | 1781 | 0.040 |
Why?
|
| Collectins | 1 | 1999 | 18 | 0.040 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 715 | 0.040 |
Why?
|
| Nuclear Proteins | 3 | 2001 | 5854 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2002 | 3772 | 0.040 |
Why?
|
| Punctures | 1 | 2000 | 374 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 2203 | 0.040 |
Why?
|
| Models, Biological | 1 | 2015 | 9582 | 0.040 |
Why?
|
| Cartilage, Articular | 1 | 2006 | 1095 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2009 | 2951 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2000 | 320 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2019 | 363 | 0.040 |
Why?
|
| Rats | 4 | 2007 | 24250 | 0.040 |
Why?
|
| Candidiasis | 1 | 2001 | 366 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8430 | 0.040 |
Why?
|
| SAIDS Vaccines | 1 | 2000 | 166 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2006 | 4009 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 574 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2014 | 8436 | 0.040 |
Why?
|
| Complementarity Determining Regions | 1 | 2019 | 149 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2003 | 652 | 0.040 |
Why?
|
| Apoferritins | 1 | 1998 | 18 | 0.040 |
Why?
|
| Pain | 1 | 2013 | 4987 | 0.040 |
Why?
|
| Virus Replication | 1 | 2006 | 2535 | 0.040 |
Why?
|
| Calreticulin | 1 | 1999 | 98 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 1 | 1999 | 286 | 0.040 |
Why?
|
| Glomerular Mesangium | 1 | 1998 | 108 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 1999 | 291 | 0.040 |
Why?
|
| Aqueous Humor | 1 | 1998 | 161 | 0.040 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 1997 | 42 | 0.040 |
Why?
|
| Binding Sites | 4 | 2001 | 6111 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 1311 | 0.040 |
Why?
|
| Mycobacterium avium Complex | 1 | 1997 | 60 | 0.040 |
Why?
|
| Plasmodium yoelii | 1 | 1997 | 39 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 1092 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2014 | 3445 | 0.040 |
Why?
|
| Erythrocytes | 3 | 2002 | 2455 | 0.040 |
Why?
|
| Insect Proteins | 1 | 1999 | 255 | 0.040 |
Why?
|
| Cell Death | 2 | 2017 | 1705 | 0.040 |
Why?
|
| Neck | 1 | 2002 | 698 | 0.040 |
Why?
|
| Child | 2 | 2023 | 77637 | 0.040 |
Why?
|
| Protein Array Analysis | 1 | 2019 | 411 | 0.040 |
Why?
|
| Receptors, Erythropoietin | 1 | 1997 | 147 | 0.040 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 1997 | 97 | 0.040 |
Why?
|
| Disease Progression | 2 | 2016 | 13273 | 0.040 |
Why?
|
| Interleukin-1alpha | 1 | 2017 | 85 | 0.040 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1997 | 110 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1997 | 1159 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2018 | 144 | 0.040 |
Why?
|
| Organ Size | 1 | 2002 | 2241 | 0.040 |
Why?
|
| Pneumonia, Aspiration | 1 | 1997 | 145 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2000 | 780 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1999 | 520 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 1997 | 273 | 0.040 |
Why?
|
| Dermatitis, Contact | 1 | 1996 | 129 | 0.030 |
Why?
|
| Adenoma | 1 | 2007 | 2173 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2002 | 1821 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 2001 | 1074 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 3510 | 0.030 |
Why?
|
| Langerhans Cells | 1 | 1996 | 173 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1987 | 769 | 0.030 |
Why?
|
| Mice, SCID | 3 | 2009 | 2718 | 0.030 |
Why?
|
| Adult | 5 | 2023 | 213889 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 245 | 0.030 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 1986 | 98 | 0.030 |
Why?
|
| Mycobacterium | 1 | 1997 | 248 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2004 | 2500 | 0.030 |
Why?
|
| Wound Healing | 1 | 2007 | 2776 | 0.030 |
Why?
|
| Retroviridae | 2 | 2000 | 913 | 0.030 |
Why?
|
| Anemia, Hemolytic | 1 | 1996 | 168 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1999 | 1369 | 0.030 |
Why?
|
| Burns | 1 | 2007 | 1815 | 0.030 |
Why?
|
| Skin | 3 | 2012 | 4372 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2000 | 570 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3917 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2150 | 0.030 |
Why?
|
| Tyrosine | 1 | 2000 | 1462 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2020 | 971 | 0.030 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1995 | 118 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2020 | 4221 | 0.030 |
Why?
|
| Pregnancy | 4 | 2012 | 29140 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 19894 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2017 | 324 | 0.030 |
Why?
|
| Acute Disease | 3 | 2000 | 7150 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2000 | 1125 | 0.030 |
Why?
|
| Chorioallantoic Membrane | 1 | 2015 | 47 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1986 | 1374 | 0.030 |
Why?
|
| Growth Inhibitors | 1 | 1996 | 385 | 0.030 |
Why?
|
| Hemolysis | 3 | 1992 | 420 | 0.030 |
Why?
|
| Swine | 3 | 2016 | 5909 | 0.030 |
Why?
|
| Cytosol | 1 | 2018 | 901 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 560 | 0.030 |
Why?
|
| Corneal Transplantation | 1 | 1999 | 384 | 0.030 |
Why?
|
| Simian immunodeficiency virus | 1 | 2000 | 846 | 0.030 |
Why?
|
| Cercopithecidae | 1 | 1994 | 22 | 0.030 |
Why?
|
| Introns | 2 | 1994 | 991 | 0.030 |
Why?
|
| B-Cell Activating Factor | 1 | 2014 | 119 | 0.030 |
Why?
|
| Ubiquitins | 1 | 1996 | 384 | 0.030 |
Why?
|
| Chemistry | 2 | 1987 | 352 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 3504 | 0.030 |
Why?
|
| Chemical Phenomena | 2 | 1987 | 518 | 0.030 |
Why?
|
| Intestinal Diseases | 1 | 1999 | 531 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2000 | 3701 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 1999 | 1081 | 0.030 |
Why?
|
| Immune System | 2 | 2014 | 807 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2002 | 10251 | 0.030 |
Why?
|
| Micelles | 1 | 2014 | 203 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2016 | 961 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1997 | 902 | 0.030 |
Why?
|
| Transplantation Chimera | 2 | 2006 | 613 | 0.030 |
Why?
|
| Multiple Sclerosis | 3 | 2011 | 3079 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2002 | 3205 | 0.030 |
Why?
|
| Cell Division | 2 | 1998 | 4568 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2013 | 222 | 0.030 |
Why?
|
| Hemolysin Proteins | 1 | 2013 | 113 | 0.030 |
Why?
|
| Trachea | 1 | 2019 | 1076 | 0.030 |
Why?
|
| Frozen Sections | 1 | 2014 | 155 | 0.030 |
Why?
|
| Basement Membrane | 3 | 1999 | 357 | 0.030 |
Why?
|
| Immediate-Early Proteins | 1 | 1996 | 453 | 0.030 |
Why?
|
| Glycopeptides | 1 | 2014 | 226 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2000 | 1904 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 1997 | 706 | 0.030 |
Why?
|
| Dendrites | 1 | 2016 | 485 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2013 | 153 | 0.030 |
Why?
|
| Virus Internalization | 1 | 2017 | 501 | 0.030 |
Why?
|
| Brain Edema | 2 | 2008 | 617 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2015 | 983 | 0.030 |
Why?
|
| Genes, Essential | 1 | 2014 | 183 | 0.030 |
Why?
|
| Endothelium, Lymphatic | 1 | 2012 | 58 | 0.030 |
Why?
|
| H-2 Antigens | 2 | 2004 | 366 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2012 | 95 | 0.030 |
Why?
|
| Survival Rate | 1 | 2007 | 12786 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2012 | 121 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1996 | 2839 | 0.030 |
Why?
|
| Chromatography, Agarose | 1 | 2011 | 28 | 0.030 |
Why?
|
| Immunoglobulin Switch Region | 1 | 1992 | 46 | 0.030 |
Why?
|
| Cyanogen Bromide | 1 | 1991 | 73 | 0.030 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2012 | 54 | 0.030 |
Why?
|
| Acute-Phase Reaction | 1 | 2012 | 92 | 0.030 |
Why?
|
| Galactosylceramides | 1 | 2012 | 92 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1996 | 1263 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2012 | 96 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 7719 | 0.030 |
Why?
|
| Hydroxylamines | 1 | 1991 | 40 | 0.030 |
Why?
|
| Amides | 1 | 2014 | 459 | 0.030 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 323 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 556 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2012 | 142 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1991 | 278 | 0.020 |
Why?
|
| Plasmids | 3 | 1992 | 2308 | 0.020 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2002 | 90 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14714 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1876 | 0.020 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2011 | 130 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 237 | 0.020 |
Why?
|
| Microinjections | 1 | 2012 | 326 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 291 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 354 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 241 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2000 | 2440 | 0.020 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2018 | 933 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 20827 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 1420 | 0.020 |
Why?
|
| Liposomes | 1 | 2014 | 759 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 5532 | 0.020 |
Why?
|
| Zymosan | 2 | 2001 | 124 | 0.020 |
Why?
|
| Troponin T | 1 | 2016 | 754 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2009 | 0.020 |
Why?
|
| Aging | 1 | 2009 | 8655 | 0.020 |
Why?
|
| Multigene Family | 1 | 1994 | 1101 | 0.020 |
Why?
|
| Cricetulus | 1 | 2012 | 818 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2001 | 370 | 0.020 |
Why?
|
| Genetic Vectors | 3 | 2000 | 3421 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 553 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 418 | 0.020 |
Why?
|
| Endothelium, Vascular | 2 | 2000 | 4459 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 427 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 1999 | 1580 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1995 | 2725 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 2029 | 0.020 |
Why?
|
| Age Factors | 1 | 2007 | 18355 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2015 | 2963 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 12066 | 0.020 |
Why?
|
| Complement Hemolytic Activity Assay | 2 | 2000 | 9 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2000 | 2942 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2009 | 87 | 0.020 |
Why?
|
| CHO Cells | 1 | 2012 | 1409 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 2556 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2018 | 2132 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2014 | 1185 | 0.020 |
Why?
|
| Hyperalgesia | 1 | 2013 | 502 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 644 | 0.020 |
Why?
|
| Hydrogels | 1 | 2014 | 727 | 0.020 |
Why?
|
| Kinetics | 2 | 2001 | 6476 | 0.020 |
Why?
|
| Bacteriophages | 1 | 1992 | 356 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2001 | 2304 | 0.020 |
Why?
|
| Histones | 1 | 1999 | 2598 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2014 | 708 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1996 | 1178 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 1989 | 131 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 2475 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2012 | 674 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 1989 | 318 | 0.020 |
Why?
|
| Leukemia | 1 | 1996 | 1509 | 0.020 |
Why?
|
| Dinitrofluorobenzene | 2 | 1998 | 16 | 0.020 |
Why?
|
| Vaccinia virus | 2 | 2000 | 349 | 0.020 |
Why?
|
| Exons | 1 | 1994 | 2438 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10940 | 0.020 |
Why?
|
| Edema | 2 | 2004 | 789 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2000 | 1968 | 0.020 |
Why?
|
| Axons | 1 | 2016 | 1685 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2012 | 981 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1989 | 352 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2013 | 1351 | 0.020 |
Why?
|
| Malaria | 1 | 1997 | 1239 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2008 | 253 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 2 | 2012 | 3587 | 0.020 |
Why?
|
| Liver | 5 | 2008 | 7479 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2001 | 3338 | 0.020 |
Why?
|
| Lysosomes | 1 | 2012 | 893 | 0.020 |
Why?
|
| Boston | 1 | 2020 | 9310 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2014 | 1903 | 0.020 |
Why?
|
| Curriculum | 1 | 2020 | 3603 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1986 | 170 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 1997 | 5867 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1702 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2002 | 3712 | 0.020 |
Why?
|
| Salmonella enteritidis | 2 | 1996 | 17 | 0.020 |
Why?
|
| Complement Factor H | 1 | 2006 | 110 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2008 | 757 | 0.020 |
Why?
|
| Methacholine Chloride | 1 | 2006 | 233 | 0.020 |
Why?
|
| Complement C1 | 2 | 1998 | 33 | 0.020 |
Why?
|
| Action Potentials | 1 | 2013 | 1804 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2007 | 1162 | 0.020 |
Why?
|
| Blood Platelets | 2 | 2012 | 2509 | 0.020 |
Why?
|
| Amino Acids | 1 | 1992 | 1733 | 0.020 |
Why?
|
| Genomic Library | 2 | 1996 | 193 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2013 | 1212 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 424 | 0.020 |
Why?
|
| Finland | 1 | 1987 | 602 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 2988 | 0.020 |
Why?
|
| Polyomavirus | 1 | 2006 | 249 | 0.020 |
Why?
|
| Vero Cells | 1 | 2006 | 485 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 478 | 0.020 |
Why?
|
| Rhadinovirus | 1 | 2005 | 37 | 0.020 |
Why?
|
| Albuminuria | 2 | 2000 | 681 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 1999 | 1799 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2005 | 198 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 1986 | 457 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 1683 | 0.020 |
Why?
|
| Wound Infection | 1 | 2007 | 242 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2005 | 124 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 1479 | 0.020 |
Why?
|
| Peptide Library | 1 | 2006 | 349 | 0.020 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 107 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1998 | 4216 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 2003 | 964 | 0.020 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2005 | 168 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2011 | 1358 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2016 | 3106 | 0.010 |
Why?
|
| Encephalitis | 1 | 2008 | 424 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1995 | 878 | 0.010 |
Why?
|
| Polyomavirus Infections | 1 | 2006 | 200 | 0.010 |
Why?
|
| Rhabdomyolysis | 1 | 2005 | 150 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 768 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2006 | 710 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2007 | 63042 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 1523 | 0.010 |
Why?
|
| Virus Latency | 1 | 2006 | 358 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 3794 | 0.010 |
Why?
|
| Synovial Membrane | 1 | 2006 | 506 | 0.010 |
Why?
|
| Stem Cells | 3 | 2004 | 3566 | 0.010 |
Why?
|
| Y Chromosome | 1 | 2004 | 206 | 0.010 |
Why?
|
| Liver Diseases, Parasitic | 1 | 2003 | 10 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2004 | 275 | 0.010 |
Why?
|
| Praziquantel | 1 | 2003 | 25 | 0.010 |
Why?
|
| Cell Migration Inhibition | 1 | 2003 | 96 | 0.010 |
Why?
|
| Thromboxane B2 | 1 | 2003 | 152 | 0.010 |
Why?
|
| Histamine Release | 1 | 2003 | 142 | 0.010 |
Why?
|
| Echocardiography | 1 | 2016 | 5096 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6356 | 0.010 |
Why?
|
| Antigens, Helminth | 1 | 2003 | 64 | 0.010 |
Why?
|
| Viral Matrix Proteins | 1 | 2004 | 186 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2327 | 0.010 |
Why?
|
| Digestive System | 1 | 2004 | 253 | 0.010 |
Why?
|
| Capsid Proteins | 1 | 2006 | 479 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1993 | 5445 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2010 | 5179 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8316 | 0.010 |
Why?
|
| Substance P | 1 | 2003 | 335 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2001 | 25609 | 0.010 |
Why?
|
| Serum | 1 | 2003 | 214 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 2001 | 40 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 4033 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1985 | 547 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2566 | 0.010 |
Why?
|
| Complement Fixation Tests | 1 | 2001 | 78 | 0.010 |
Why?
|
| Arthus Reaction | 1 | 2001 | 14 | 0.010 |
Why?
|
| Necrosis | 1 | 2006 | 1642 | 0.010 |
Why?
|
| Schistosoma mansoni | 1 | 2003 | 149 | 0.010 |
Why?
|
| Cytidine Deaminase | 1 | 2004 | 252 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1994 | 1085 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1994 | 798 | 0.010 |
Why?
|
| Scrapie | 1 | 2001 | 22 | 0.010 |
Why?
|
| Cryptococcosis | 1 | 2002 | 101 | 0.010 |
Why?
|
| Placenta | 1 | 2010 | 1699 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2006 | 3389 | 0.010 |
Why?
|
| Hematopoiesis | 2 | 2004 | 2073 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16674 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1992 | 829 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 2378 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1985 | 1063 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 2274 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2001 | 251 | 0.010 |
Why?
|
| Proteins | 1 | 1996 | 6098 | 0.010 |
Why?
|
| Cell Adhesion | 2 | 1997 | 3144 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1999 | 7172 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2000 | 113 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 1986 | 0.010 |
Why?
|
| Ikaros Transcription Factor | 1 | 2001 | 217 | 0.010 |
Why?
|
| Genetic Code | 1 | 1980 | 154 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 2002 | 477 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1986 | 1811 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3778 | 0.010 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1999 | 95 | 0.010 |
Why?
|
| Graft Survival | 2 | 2001 | 3734 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2012 | 3482 | 0.010 |
Why?
|
| Pasteurella | 1 | 1998 | 6 | 0.010 |
Why?
|
| Blood Pressure | 2 | 2007 | 8551 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2000 | 251 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 1999 | 68 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2012 | 5096 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 2000 | 129 | 0.010 |
Why?
|
| Prions | 1 | 2001 | 180 | 0.010 |
Why?
|
| Genotype | 2 | 2002 | 12944 | 0.010 |
Why?
|
| Poliovirus | 1 | 1999 | 109 | 0.010 |
Why?
|
| Immune Sera | 1 | 1999 | 641 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1984 | 1728 | 0.010 |
Why?
|
| Factor IX | 1 | 1998 | 77 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 6311 | 0.010 |
Why?
|
| Cattle | 1 | 1985 | 3917 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2000 | 743 | 0.010 |
Why?
|
| Melanocytes | 1 | 2002 | 515 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 2001 | 365 | 0.010 |
Why?
|
| Streptococcus | 1 | 1998 | 197 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 1623 | 0.010 |
Why?
|
| Magnesium | 1 | 2001 | 813 | 0.010 |
Why?
|
| Candida albicans | 1 | 2001 | 394 | 0.010 |
Why?
|
| Complement C2a | 1 | 1997 | 1 | 0.010 |
Why?
|
| Photosensitivity Disorders | 1 | 1998 | 77 | 0.010 |
Why?
|
| Isoflurophate | 1 | 1997 | 36 | 0.010 |
Why?
|
| Virus Integration | 1 | 2000 | 299 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 21733 | 0.010 |
Why?
|
| Genomics | 1 | 2014 | 5714 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2004 | 1211 | 0.010 |
Why?
|
| Receptors, Interleukin-5 | 1 | 1997 | 19 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1986 | 2266 | 0.010 |
Why?
|
| Mycobacterium leprae | 1 | 1997 | 94 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1998 | 670 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 2922 | 0.010 |
Why?
|
| Lymphoma, T-Cell | 1 | 2000 | 299 | 0.010 |
Why?
|
| Skin Physiological Phenomena | 1 | 1998 | 180 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2002 | 881 | 0.010 |
Why?
|
| Morbidity | 1 | 2003 | 1768 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 4477 | 0.010 |
Why?
|
| Mycobacterium bovis | 1 | 1997 | 150 | 0.010 |
Why?
|
| Leukotriene B4 | 1 | 1997 | 294 | 0.010 |
Why?
|
| Viremia | 1 | 2000 | 736 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1996 | 96 | 0.010 |
Why?
|
| Horses | 1 | 1997 | 304 | 0.010 |
Why?
|
| Colon | 1 | 2004 | 1772 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 15518 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 2008 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2003 | 2077 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2000 | 1794 | 0.010 |
Why?
|
| Genes, Immediate-Early | 1 | 1996 | 101 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1996 | 484 | 0.010 |
Why?
|
| Recombination, Genetic | 2 | 1994 | 1586 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2000 | 1266 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 53250 | 0.010 |
Why?
|
| E-Selectin | 1 | 1997 | 579 | 0.010 |
Why?
|
| P-Selectin | 1 | 1997 | 601 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2001 | 1301 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1997 | 674 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1997 | 675 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2000 | 1224 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2002 | 2749 | 0.010 |
Why?
|
| Aorta | 1 | 2002 | 2062 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39001 | 0.010 |
Why?
|
| Haploidy | 2 | 1986 | 136 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 1994 | 104 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 1888 | 0.010 |
Why?
|
| Endotoxins | 1 | 1996 | 527 | 0.010 |
Why?
|
| Syndrome | 1 | 2000 | 3249 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 1328 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2000 | 2375 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1999 | 1608 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4931 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2015 | 40964 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1998 | 1060 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 4777 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 2050 | 0.010 |
Why?
|
| Bacteremia | 1 | 1999 | 963 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2002 | 3208 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2001 | 2241 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 2938 | 0.010 |
Why?
|
| Protozoan Proteins | 1 | 1997 | 825 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1999 | 1988 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1995 | 1263 | 0.010 |
Why?
|
| Primates | 1 | 1994 | 545 | 0.010 |
Why?
|
| Autoradiography | 1 | 1992 | 745 | 0.010 |
Why?
|
| Esters | 1 | 1992 | 210 | 0.010 |
Why?
|
| Viral Load | 1 | 2000 | 3300 | 0.010 |
Why?
|
| Death | 1 | 1995 | 678 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 1996 | 931 | 0.010 |
Why?
|
| Calcium | 1 | 2003 | 5755 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 56392 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1994 | 2256 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 72252 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1992 | 1723 | 0.010 |
Why?
|
| Heterozygote | 2 | 1986 | 2803 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1997 | 2969 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 7908 | 0.000 |
Why?
|
| Adolescent | 1 | 2015 | 85729 | 0.000 |
Why?
|
| Blotting, Northern | 1 | 1989 | 1581 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 8035 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1994 | 2226 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 476 | 0.000 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1997 | 1832 | 0.000 |
Why?
|
| Complement C9 | 1 | 1986 | 16 | 0.000 |
Why?
|
| Complement Activating Enzymes | 1 | 1986 | 28 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1996 | 6457 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1999 | 4398 | 0.000 |
Why?
|
| HLA-DR Antigens | 1 | 1987 | 645 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2007 | 40545 | 0.000 |
Why?
|
| Asthma | 1 | 2003 | 6010 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15067 | 0.000 |
Why?
|
| Thrombosis | 1 | 1997 | 2968 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1989 | 1079 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1994 | 2542 | 0.000 |
Why?
|
| Homozygote | 1 | 1986 | 1787 | 0.000 |
Why?
|
| Genome, Human | 1 | 1994 | 4418 | 0.000 |
Why?
|
| Celiac Disease | 1 | 1986 | 785 | 0.000 |
Why?
|
| Aged | 1 | 2007 | 163178 | 0.000 |
Why?
|
| Middle Aged | 1 | 2007 | 213241 | 0.000 |
Why?
|